New pyridine‐based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities
Archiv der Pharmazie · 2024-07 · 357 (7)
DOI: 10.1002/ardp.202400081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 28.03.2024. Verfasst von Jonathan Ramírez-Prada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Heterocyclic Compounds Research Group, Department of Chemistry, Universidad del Valle, Cali, Colombia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Chalcones, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Universidad del Valle, Ministerio de Ciencia, Tecnología e Innovación, Universidad de Antioquia.
Abstract (Originalsprache)
New pyridine‐based chalcones 4a–h and pyrazolines 5a–h ( N ‐acetyl), 6a–h ( N ‐phenyl), and 7a–h ( N ‐4‐chlorophenyl) were synthesized and evaluated by the National Cancer Institute (NCI) against 60 different human cancer cell lines. Pyrazolines 6a , 6c–h , and 7a–h satisfied the pre‐determined threshold inhibition criteria, obtaining that compounds 6c and 6f exhibited high antiproliferative activity, reaching submicromolar GI 50 values from 0.38 to 0.45 μM, respectively. Moreover, compound 7g (4‐CH 3 ) exhibited the highest cytostatic activity of these series against different cancer cell lines from leukemia, nonsmall cell lung, colon, ovarian, renal, and prostate cancer, with LC 50 values ranging from 5.41 to 8.35 μM, showing better cytotoxic activity than doxorubicin. Furthermore, the compounds were tested for antibacterial and antiplasmodial activities. Chalcone 4c was the most active with minimal inhibitory concentration (MIC) = 2 μg/mL against methicillin‐resistant Staphylococcus aureus (MRSA), while the pyrazoline 6h showed a MIC = 8 μg/mL against Neisseria gonorrhoeae . For anti‐ Plasmodium falciparum activity, the chalcones display higher activity with EC 50 values ranging from 10.26 to 10.94 μg/mL. Docking studies were conducted against relevant proteins from P. falciparum , exhibiting the minimum binding energy with plasmepsin II. In vivo toxicity assay in Galleria mellonella suggests that most compounds are low or nontoxic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heterocyclic Compounds Research Group, Department of Chemistry, Universidad del Valle, Cali, Colombia.
- Center for Bioinformatics and Photonics-CIBioFI, Cali, Colombia.
- Biotechnology and Bacterial Infections Research Group, Department of Microbiology, Universidad del Valle, Cali, Colombia.
- Microbiology and Infectious Diseases Research Group, Department of Microbiology, Universidad del Valle, Cali, Colombia.
- Group of Bioinformatics, Faculty of Engineering, Universidad del Valle, Cali, Colombia.
- PECET, Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Förderung
- Universidad del Valle
- Ministerio de Ciencia, Tecnología e Innovación
- Universidad de Antioquia
- Science, Technology, and Innovation Fund-General Royalties System (FCTeI-SGR) under contract BPIN 2013000100007
Zitieren
APA
Ramírez-Prada, J., Rocha-Ortiz, J. S., Orozco, M. I., Moreno, P., Guevara, M., Barreto, M., Burbano, M. E., Robledo, S., Crespo-Ortiz, M. D. P., Quiroga, J., Abonia, R., Cuartas, V., & Insuasty, B. (2024). New pyridine‐based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities. Archiv der Pharmazie, 357(7). https://doi.org/10.1002/ardp.202400081
Vancouver
Ramírez-Prada J, Rocha-Ortiz JS, Orozco MI, Moreno P, Guevara M, Barreto M, et al. New pyridine‐based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities. Archiv der Pharmazie. 2024;357(7). doi:10.1002/ardp.202400081
BibTeX
@article{RamrezPrada2024,
author = {Ramírez-Prada, Jonathan and Rocha-Ortiz, Juan S and Orozco, Marta I and Moreno, Pedro and Guevara, Miguel and Barreto, Mauricio and Burbano, Maria E and Robledo, Sara and Crespo-Ortiz, Maria Del Pilar and Quiroga, Jairo and Abonia, Rodrigo and Cuartas, Viviana and Insuasty, Braulio},
title = {New pyridine‐based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities},
journal = {Archiv der Pharmazie},
year = {2024},
volume = {357},
number = {7},
doi = {10.1002/ardp.202400081}
}
EUVIMED